IN2014MN02658A
(US07794700-20100914-C00152.png)
|
2012-06-08 |
2015-08-21 |
Gilead Sciences Inc |
|
ES2624223T3
(es)
*
|
2012-06-08 |
2017-07-13 |
Gilead Sciences, Inc. |
Inhibidores macrocíclicos de los virus flaviviridae
|
AR091279A1
(es)
*
|
2012-06-08 |
2015-01-21 |
Gilead Sciences Inc |
Inhibidores macrociclicos de virus flaviviridae
|
EP3087085B1
(en)
*
|
2013-12-23 |
2019-02-20 |
Gilead Sciences, Inc. |
Synthesis of a macrocyclic hcv ns3 inhibiting tripeptide
|
EP3194401B1
(en)
|
2014-09-16 |
2020-10-21 |
Gilead Sciences, Inc. |
Solid forms of a toll-like receptor modulator
|
ES2892123T3
(es)
|
2014-12-26 |
2022-02-02 |
Univ Emory |
Derivados antivíricos de N4-hidroxicitidina
|
CN107108615B
(zh)
|
2015-03-04 |
2020-11-20 |
吉利德科学公司 |
Toll样受体调节性4,6-二氨基-吡啶并[3,2-D]嘧啶化合物
|
US20210292327A1
(en)
|
2015-08-26 |
2021-09-23 |
Gilead Sciences, Inc. |
Deuterated toll-like receptor modulators
|
CN109562113A
(zh)
|
2016-05-10 |
2019-04-02 |
C4医药公司 |
用于靶蛋白降解的螺环降解决定子体
|
WO2017197046A1
(en)
|
2016-05-10 |
2017-11-16 |
C4 Therapeutics, Inc. |
C3-carbon linked glutarimide degronimers for target protein degradation
|
WO2017197055A1
(en)
|
2016-05-10 |
2017-11-16 |
C4 Therapeutics, Inc. |
Heterocyclic degronimers for target protein degradation
|
BR102017010009A2
(pt)
|
2016-05-27 |
2017-12-12 |
Gilead Sciences, Inc. |
Compounds for the treatment of hepatitis b virus infection
|
US11738013B2
(en)
|
2016-05-27 |
2023-08-29 |
Gilead Sciences, Inc. |
Methods for treating hepatitis B virus infections using NS5A, NS5B or NS3 inhibitors
|
JOP20190024A1
(ar)
|
2016-08-26 |
2019-02-19 |
Gilead Sciences Inc |
مركبات بيروليزين بها استبدال واستخداماتها
|
US10640499B2
(en)
|
2016-09-02 |
2020-05-05 |
Gilead Sciences, Inc. |
Toll like receptor modulator compounds
|
EP3507276B1
(en)
|
2016-09-02 |
2021-11-03 |
Gilead Sciences, Inc. |
Toll like receptor modulator compounds
|
DK3526323T3
(da)
|
2016-10-14 |
2023-06-26 |
Prec Biosciences Inc |
Modificerede meganucleaser der er specifikke for en genkendelsessekvens i hepatitis b virusgenomet
|
AR110768A1
(es)
|
2017-01-31 |
2019-05-02 |
Gilead Sciences Inc |
Formas cristalinas de tenofovir alafenamida
|
JOP20180008A1
(ar)
|
2017-02-02 |
2019-01-30 |
Gilead Sciences Inc |
مركبات لعلاج إصابة بعدوى فيروس الالتهاب الكبدي b
|
JOP20180040A1
(ar)
|
2017-04-20 |
2019-01-30 |
Gilead Sciences Inc |
مثبطات pd-1/pd-l1
|
WO2019040102A1
(en)
|
2017-08-22 |
2019-02-28 |
Gilead Sciences, Inc. |
THERAPEUTIC HETEROCYCLIC COMPOUNDS
|
GB2581936B
(en)
|
2017-12-07 |
2021-02-10 |
Univ Emory |
N4-hydroxycytidine and derivatives and anti-viral uses related thereto
|
AU2018392212B9
(en)
|
2017-12-20 |
2021-03-18 |
Institute Of Organic Chemistry And Biochemistry Ascr, V.V.I. |
2'3' cyclic dinucleotides with phosphonate bond activating the STING adaptor protein
|
EP3728283B1
(en)
|
2017-12-20 |
2023-11-22 |
Institute of Organic Chemistry and Biochemistry ASCR, V.V.I. |
3'3' cyclic dinucleotides with phosphonate bond activating the sting adaptor protein
|
SG11202007646UA
(en)
|
2018-02-13 |
2020-09-29 |
Gilead Sciences Inc |
Pd-1/pd-l1 inhibitors
|
CN111788204B
(zh)
|
2018-02-26 |
2023-05-05 |
吉利德科学公司 |
作为hbv复制抑制剂的取代吡咯嗪化合物
|
US10870691B2
(en)
|
2018-04-05 |
2020-12-22 |
Gilead Sciences, Inc. |
Antibodies and fragments thereof that bind hepatitis B virus protein X
|
TWI818007B
(zh)
|
2018-04-06 |
2023-10-11 |
捷克科學院有機化學與生物化學研究所 |
2'3'-環二核苷酸
|
TW202005654A
(zh)
|
2018-04-06 |
2020-02-01 |
捷克科學院有機化學與生物化學研究所 |
2,2,─環二核苷酸
|
TWI833744B
(zh)
|
2018-04-06 |
2024-03-01 |
捷克科學院有機化學與生物化學研究所 |
3'3'-環二核苷酸
|
TW201945388A
(zh)
|
2018-04-12 |
2019-12-01 |
美商精密生物科學公司 |
對b型肝炎病毒基因體中之識別序列具有特異性之最佳化之經工程化巨核酸酶
|
TWI712412B
(zh)
|
2018-04-19 |
2020-12-11 |
美商基利科學股份有限公司 |
Pd‐1/pd‐l1抑制劑
|
WO2019211799A1
(en)
|
2018-05-03 |
2019-11-07 |
Institute Of Organic Chemistry And Biochemistry Ascr, V.V.I. |
2'3'-cyclic dinucleotide analogue comprising a cyclopentanyl modified nucleotide
|
KR102629921B1
(ko)
|
2018-07-06 |
2024-01-31 |
길리애드 사이언시즈, 인코포레이티드 |
치료 헤테로시클릭 화합물
|
CA3103987C
(en)
|
2018-07-06 |
2023-08-01 |
Gilead Sciences, Inc. |
Therapeutic heterocyclic compounds
|
TWI732245B
(zh)
|
2018-07-13 |
2021-07-01 |
美商基利科學股份有限公司 |
Pd‐1/pd‐l1抑制劑
|
WO2020028097A1
(en)
|
2018-08-01 |
2020-02-06 |
Gilead Sciences, Inc. |
Solid forms of (r)-11-(methoxymethyl)-12-(3-methoxypropoxy)-3,3-dimethyl-8-0x0-2,3,8,13b-tetrahydro-1h-pyrido[2,1-a]pyrrolo[1,2-c] phthalazine-7-c arboxylic acid
|
CN112955435A
(zh)
|
2018-10-24 |
2021-06-11 |
吉利德科学公司 |
Pd-1/pd-l1抑制剂
|
WO2020092528A1
(en)
|
2018-10-31 |
2020-05-07 |
Gilead Sciences, Inc. |
Substituted 6-azabenzimidazole compounds having hpk1 inhibitory activity
|
JP7460644B2
(ja)
|
2018-10-31 |
2024-04-02 |
ギリアード サイエンシーズ, インコーポレイテッド |
Hpk1阻害剤としての置換6-アザベンゾイミダゾール化合物
|
EP3935065A1
(en)
|
2019-03-07 |
2022-01-12 |
Institute of Organic Chemistry and Biochemistry ASCR, V.V.I. |
3'3'-cyclic dinucleotide analogue comprising a cyclopentanyl modified nucleotide as sting modulator
|
EP3934757B1
(en)
|
2019-03-07 |
2023-02-22 |
Institute of Organic Chemistry and Biochemistry ASCR, V.V.I. |
2'3'-cyclic dinucleotides and prodrugs thereof
|
AU2020231115A1
(en)
|
2019-03-07 |
2021-08-26 |
Institute Of Organic Chemistry And Biochemistry Ascr, V.V.I. |
3'3'-cyclic dinucleotides and prodrugs thereof
|
TW202212339A
(zh)
|
2019-04-17 |
2022-04-01 |
美商基利科學股份有限公司 |
類鐸受體調節劑之固體形式
|
TW202210480A
(zh)
|
2019-04-17 |
2022-03-16 |
美商基利科學股份有限公司 |
類鐸受體調節劑之固體形式
|
TWI826690B
(zh)
|
2019-05-23 |
2023-12-21 |
美商基利科學股份有限公司 |
經取代之烯吲哚酮化物及其用途
|
CA3140708A1
(en)
|
2019-06-18 |
2020-12-24 |
Helen Horton |
Combination of hepatitis b virus (hbv) vaccines and pyridopyrimidine derivatives
|
EP3990476A1
(en)
|
2019-06-25 |
2022-05-04 |
Gilead Sciences, Inc. |
Flt3l-fc fusion proteins and methods of use
|
WO2021011891A1
(en)
|
2019-07-18 |
2021-01-21 |
Gilead Sciences, Inc. |
Long-acting formulations of tenofovir alafenamide
|
EP4017476A1
(en)
|
2019-08-19 |
2022-06-29 |
Gilead Sciences, Inc. |
Pharmaceutical formulations of tenofovir alafenamide
|
CA3149557A1
(en)
|
2019-09-30 |
2021-04-08 |
Scott J. Balsitis |
Hbv vaccines and methods treating hbv
|
CN114867735A
(zh)
|
2019-11-04 |
2022-08-05 |
锐新医药公司 |
Ras抑制剂
|
CN115873020A
(zh)
|
2019-11-04 |
2023-03-31 |
锐新医药公司 |
Ras抑制剂
|
EP4054719A1
(en)
|
2019-11-04 |
2022-09-14 |
Revolution Medicines, Inc. |
Ras inhibitors
|
CN116057068A
(zh)
|
2019-12-06 |
2023-05-02 |
精密生物科学公司 |
对乙型肝炎病毒基因组中的识别序列具有特异性的优化的工程化大范围核酸酶
|
AU2021237718B2
(en)
|
2020-03-20 |
2023-09-21 |
Gilead Sciences, Inc. |
Prodrugs of 4'-C-substituted-2-halo-2'-deoxyadenosine nucleosides and methods of making and using the same
|
WO2022031894A1
(en)
|
2020-08-07 |
2022-02-10 |
Gilead Sciences, Inc. |
Prodrugs of phosphonamide nucleotide analogues and their pharmaceutical use
|
PE20231207A1
(es)
|
2020-09-15 |
2023-08-17 |
Revolution Medicines Inc |
Derivados indolicos como inhibidores de ras en el tratamiento del cancer
|
TW202406932A
(zh)
|
2020-10-22 |
2024-02-16 |
美商基利科學股份有限公司 |
介白素2-Fc融合蛋白及使用方法
|
EP4074317A1
(en)
|
2021-04-14 |
2022-10-19 |
Bayer AG |
Phosphorus derivatives as novel sos1 inhibitors
|
AU2022274607A1
(en)
|
2021-05-13 |
2023-11-16 |
Gilead Sciences, Inc. |
COMBINATION OF A TLR8 MODULATING COMPOUND AND ANTI-HBV siRNA THERAPEUTICS
|
WO2022271650A1
(en)
|
2021-06-23 |
2022-12-29 |
Gilead Sciences, Inc. |
Diacylglyercol kinase modulating compounds
|
EP4359415A1
(en)
|
2021-06-23 |
2024-05-01 |
Gilead Sciences, Inc. |
Diacylglyercol kinase modulating compounds
|
CN117480155A
(zh)
|
2021-06-23 |
2024-01-30 |
吉利德科学公司 |
二酰基甘油激酶调节化合物
|
CA3222439A1
(en)
|
2021-06-23 |
2022-12-29 |
Gilead Sciences, Inc. |
Diacylglyercol kinase modulating compounds
|
CN114796193B
(zh)
*
|
2022-05-13 |
2023-07-18 |
黑龙江八一农垦大学 |
抗牛病毒性腹泻病毒的中药单体
|